Active
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today gonna be good...be ready for profit taking tomorrow
Mornin' Mitch. U must be doin pretty good on MIIX huh?
Bids are STACKING boys/girls
Great post I like the way you think
Vey nice pck I've been playing that one for a couple of month on and off, gets great volume on runs
You guys r missing a nice merger play one of the companies is way oversold too. RUL, Brick, I'm surprised
Morning all. I'm super heavy on CBAI since yesterday hopefully today's clearification pushes it to pennyland for good. Not a 5 bagger s/t, but l/t definitely more than that
Guys lets say goodbye to 00's for good today
All in due time... 00's will be a memory, peeps will wish they had bought now...been here before and I'm steadfast on this one
Im gonna rally some troops for tomorrow; plus we have more news coming down the pipe and solid support here imo
MACD and RSI lookin good tomorrow should be fun
I know but it ticked back up lol
Take em out boys *pennyland*
I don't see any validity to that comment
Thats terrible, spamming? Wow... ok
Peeps at BOSS...we'll see!!
Im hearing the big boys will be on this by EOD... hold tight
Ya buddy!
Walkin back up now
Agreed why no sticky for news?
RSI lookin very good now
Buy now or chase...
Should leave 00's behind for good today imo
Im heavy long on this one for a reason
Bids stacked @ .0095, let em chase it
CBAI just announced: Cord Blood America Acquires Controlling Interest in One of Germany's Largest Cord Blood Storage Companies
10:52a ET March 24, 2010 (PR NewsWire)
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.
"Europe is quickly becoming a global force in the storage of stem cells for future medical use. We believe this acquisition is a perfect example of our business strategy to use acquisitions as part of the process to grow Cord Blood America into a major stem cell storage company globally," said Matthew Schissler, Cord Blood America co-founder and CEO.
stellacure (www.stellacure.com) is headquartered in Hamburg, Germany. It began storing cord blood for families in 2006 throughout Germany, and within the past year has established sales channels in Spain and Italy. It operates in conjunction with the German Red Cross Bloodservices Baden-Wuerttemberg/Hessen, which has collected cord blood for a public bank since 1996.
"Becoming a 51% stakeholder of one of Europe's most meaningful stem cell banking companies is extremely important for us to carry out our goal of becoming the globally dominant stem cell storage company. We see acquiring a majority stake in stellacure as an important first step to further penetrate other European markets. CBAI is extremely pleased that it was chosen as stellacure's preferred partner to foster further growth of the company and equally excited to establish a long term relationship with the largest blood service unit of the German Red Cross, as we all know a respected name globally," Mr. Schissler said.
The transaction was introduced by specialist life sciences advisory firm CFP BioConnect AG, based in Frankfurt/Germany.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
CBAI just announced: Cord Blood America Acquires Controlling Interest in One of Germany's Largest Cord Blood Storage Companies
10:52a ET March 24, 2010 (PR NewsWire)
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.
"Europe is quickly becoming a global force in the storage of stem cells for future medical use. We believe this acquisition is a perfect example of our business strategy to use acquisitions as part of the process to grow Cord Blood America into a major stem cell storage company globally," said Matthew Schissler, Cord Blood America co-founder and CEO.
stellacure (www.stellacure.com) is headquartered in Hamburg, Germany. It began storing cord blood for families in 2006 throughout Germany, and within the past year has established sales channels in Spain and Italy. It operates in conjunction with the German Red Cross Bloodservices Baden-Wuerttemberg/Hessen, which has collected cord blood for a public bank since 1996.
"Becoming a 51% stakeholder of one of Europe's most meaningful stem cell banking companies is extremely important for us to carry out our goal of becoming the globally dominant stem cell storage company. We see acquiring a majority stake in stellacure as an important first step to further penetrate other European markets. CBAI is extremely pleased that it was chosen as stellacure's preferred partner to foster further growth of the company and equally excited to establish a long term relationship with the largest blood service unit of the German Red Cross, as we all know a respected name globally," Mr. Schissler said.
The transaction was introduced by specialist life sciences advisory firm CFP BioConnect AG, based in Frankfurt/Germany.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
CBAI just announced: Cord Blood America Acquires Controlling Interest in One of Germany's Largest Cord Blood Storage Companies
10:52a ET March 24, 2010 (PR NewsWire)
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.
"Europe is quickly becoming a global force in the storage of stem cells for future medical use. We believe this acquisition is a perfect example of our business strategy to use acquisitions as part of the process to grow Cord Blood America into a major stem cell storage company globally," said Matthew Schissler, Cord Blood America co-founder and CEO.
stellacure (www.stellacure.com) is headquartered in Hamburg, Germany. It began storing cord blood for families in 2006 throughout Germany, and within the past year has established sales channels in Spain and Italy. It operates in conjunction with the German Red Cross Bloodservices Baden-Wuerttemberg/Hessen, which has collected cord blood for a public bank since 1996.
"Becoming a 51% stakeholder of one of Europe's most meaningful stem cell banking companies is extremely important for us to carry out our goal of becoming the globally dominant stem cell storage company. We see acquiring a majority stake in stellacure as an important first step to further penetrate other European markets. CBAI is extremely pleased that it was chosen as stellacure's preferred partner to foster further growth of the company and equally excited to establish a long term relationship with the largest blood service unit of the German Red Cross, as we all know a respected name globally," Mr. Schissler said.
The transaction was introduced by specialist life sciences advisory firm CFP BioConnect AG, based in Frankfurt/Germany.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
CBAI just announced: Cord Blood America Acquires Controlling Interest in One of Germany's Largest Cord Blood Storage Companies
10:52a ET March 24, 2010 (PR NewsWire)
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.
"Europe is quickly becoming a global force in the storage of stem cells for future medical use. We believe this acquisition is a perfect example of our business strategy to use acquisitions as part of the process to grow Cord Blood America into a major stem cell storage company globally," said Matthew Schissler, Cord Blood America co-founder and CEO.
stellacure (www.stellacure.com) is headquartered in Hamburg, Germany. It began storing cord blood for families in 2006 throughout Germany, and within the past year has established sales channels in Spain and Italy. It operates in conjunction with the German Red Cross Bloodservices Baden-Wuerttemberg/Hessen, which has collected cord blood for a public bank since 1996.
"Becoming a 51% stakeholder of one of Europe's most meaningful stem cell banking companies is extremely important for us to carry out our goal of becoming the globally dominant stem cell storage company. We see acquiring a majority stake in stellacure as an important first step to further penetrate other European markets. CBAI is extremely pleased that it was chosen as stellacure's preferred partner to foster further growth of the company and equally excited to establish a long term relationship with the largest blood service unit of the German Red Cross, as we all know a respected name globally," Mr. Schissler said.
The transaction was introduced by specialist life sciences advisory firm CFP BioConnect AG, based in Frankfurt/Germany.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,'' "believe,'' "expect,'' "future,'' "intend,'' "plan,'' and similar expressions to identify forward-looking statements. These statements, including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
SOURCE Cord Blood America, Inc.
In CBAI .0098 classic runner + NEWS
BGEM HUGE NEWS TODAY!!! Title Sports Drink To Be Distributed Throughout All Florida Walgreens Divisions
8:30a ET March 24, 2010 (PR NewsWire)
The Electric Beverage Company, Inc is pleased to announce that its premier sports drink, All Natural Title, has now been approved for sale in all Florida Walgreens drug stores, expanding the fast growing sports drink's distribution from South and Central Florida to all of Florida and into Southern Georgia. Title will be on middle end stands, a highly desirable presence, bringing the total number of Walgreens stores carrying Title to nearly 1000 stores. The first of the deliveries, which will be executed by Blue Gem Enterprise (OTC Bulletin Board: BGEM), Title's exclusive distributor, will occur later this week.
"We are thrilled that Walgreens has expanded our distribution to include all of Florida and now into Southern Georgia," says Sr. VP Bob Friedopfer. "They have been a huge supporter of Title and Blue Gem. We look forward to establishing a presence throughout all of Florida and building our brand in one of the top consumer markets for all isotonics in the U.S."
About Blue Gem
Blue Gem Enterprise is an emerging beverage distribution company headquartered in South Florida and serves the area from Southern Georgia through the Florida keys, including major chains, independent stores, hospitals, Gyms, Hotels and other retailers. It is the mission of Blue Gem to become one of the leading distributors of non alcoholic beverages and foods in the state of Florida.
Safe Harbor
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Blue Gem Enterprise, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such, forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and Blue Gem Enterprise does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
SOURCE Blu Gem Enterprise
BGEM HUGE NEWS TODAY!!! Title Sports Drink To Be Distributed Throughout All Florida Walgreens Divisions
8:30a ET March 24, 2010 (PR NewsWire)
The Electric Beverage Company, Inc is pleased to announce that its premier sports drink, All Natural Title, has now been approved for sale in all Florida Walgreens drug stores, expanding the fast growing sports drink's distribution from South and Central Florida to all of Florida and into Southern Georgia. Title will be on middle end stands, a highly desirable presence, bringing the total number of Walgreens stores carrying Title to nearly 1000 stores. The first of the deliveries, which will be executed by Blue Gem Enterprise (OTC Bulletin Board: BGEM), Title's exclusive distributor, will occur later this week.
"We are thrilled that Walgreens has expanded our distribution to include all of Florida and now into Southern Georgia," says Sr. VP Bob Friedopfer. "They have been a huge supporter of Title and Blue Gem. We look forward to establishing a presence throughout all of Florida and building our brand in one of the top consumer markets for all isotonics in the U.S."
About Blue Gem
Blue Gem Enterprise is an emerging beverage distribution company headquartered in South Florida and serves the area from Southern Georgia through the Florida keys, including major chains, independent stores, hospitals, Gyms, Hotels and other retailers. It is the mission of Blue Gem to become one of the leading distributors of non alcoholic beverages and foods in the state of Florida.
Safe Harbor
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Blue Gem Enterprise, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such, forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and Blue Gem Enterprise does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
SOURCE Blu Gem Enterprise
BGEM HUGE NEWS TODAY!!! Title Sports Drink To Be Distributed Throughout All Florida Walgreens Divisions
8:30a ET March 24, 2010 (PR NewsWire)
The Electric Beverage Company, Inc is pleased to announce that its premier sports drink, All Natural Title, has now been approved for sale in all Florida Walgreens drug stores, expanding the fast growing sports drink's distribution from South and Central Florida to all of Florida and into Southern Georgia. Title will be on middle end stands, a highly desirable presence, bringing the total number of Walgreens stores carrying Title to nearly 1000 stores. The first of the deliveries, which will be executed by Blue Gem Enterprise (OTC Bulletin Board: BGEM), Title's exclusive distributor, will occur later this week.
"We are thrilled that Walgreens has expanded our distribution to include all of Florida and now into Southern Georgia," says Sr. VP Bob Friedopfer. "They have been a huge supporter of Title and Blue Gem. We look forward to establishing a presence throughout all of Florida and building our brand in one of the top consumer markets for all isotonics in the U.S."
About Blue Gem
Blue Gem Enterprise is an emerging beverage distribution company headquartered in South Florida and serves the area from Southern Georgia through the Florida keys, including major chains, independent stores, hospitals, Gyms, Hotels and other retailers. It is the mission of Blue Gem to become one of the leading distributors of non alcoholic beverages and foods in the state of Florida.
Safe Harbor
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Blue Gem Enterprise, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such, forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and Blue Gem Enterprise does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
SOURCE Blu Gem Enterprise
BGEM HUGE NEWS TODAY!!! Title Sports Drink To Be Distributed Throughout All Florida Walgreens Divisions
8:30a ET March 24, 2010 (PR NewsWire)
The Electric Beverage Company, Inc is pleased to announce that its premier sports drink, All Natural Title, has now been approved for sale in all Florida Walgreens drug stores, expanding the fast growing sports drink's distribution from South and Central Florida to all of Florida and into Southern Georgia. Title will be on middle end stands, a highly desirable presence, bringing the total number of Walgreens stores carrying Title to nearly 1000 stores. The first of the deliveries, which will be executed by Blue Gem Enterprise (OTC Bulletin Board: BGEM), Title's exclusive distributor, will occur later this week.
"We are thrilled that Walgreens has expanded our distribution to include all of Florida and now into Southern Georgia," says Sr. VP Bob Friedopfer. "They have been a huge supporter of Title and Blue Gem. We look forward to establishing a presence throughout all of Florida and building our brand in one of the top consumer markets for all isotonics in the U.S."
About Blue Gem
Blue Gem Enterprise is an emerging beverage distribution company headquartered in South Florida and serves the area from Southern Georgia through the Florida keys, including major chains, independent stores, hospitals, Gyms, Hotels and other retailers. It is the mission of Blue Gem to become one of the leading distributors of non alcoholic beverages and foods in the state of Florida.
Safe Harbor
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Blue Gem Enterprise, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such, forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and Blue Gem Enterprise does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
SOURCE Blu Gem Enterprise
Bought more REMD
NXHD up 35,000%.... not bad.... lol
REMD - nice
ZVTK more news today: Zevotek Announces Ionic Bulb Appears in The Huffington Post and Marie Claire Magazine
7:01a ET March 22, 2010 (GlobeNewswire)
Zevotek, Inc., (OTCBB:ZVTK) (Frankfurt:T5V1), a worldwide direct marketer and distributor of innovative personal and home care items, today announced the Company's Ionic Bulb appeared in The Huffington Post and Marie Claire magazine's April issue that is currently on newsstands. In his Huffington Post column, Mr. Danny Seo, environment lifestyle expert, best selling author and CBS Morning Show guest contributor, describes for readers the Ionic Bulb's ability to combat indoor air pollution. The entire column can be seen at http://www.huffingtonpost.com/danny-seo/is-perfume-the-new-second_b_503114.html. According to Google Analytics, The Huffington Post has 22 million unique users each month. Technorati, an Internet search engine for blogs, ranks The Huffington Post as the most linked-to blog on the Internet.
In the April issue of Marie Claire that features Heidi Klum on its cover, Zevotek's Ionic Bulb made Fashion Editor Amanda Hearst's list of "30 Better Buys" for Spring cleaning and making life more beautiful naturally. In the list that appears on page 61, the Ionic Bulb is pictured along with the Company's newionicbulb.com web address where readers can make purchases. In Marie Claire online, Zevotek's Ionic Bulb appears on their list of "15 Eco-Friendly Better Buys". The entire list can be seen at http://www.marieclaire.com/fashion/trends/articles/better-green-buys?click=main_sr.
Commenting on the announcement, Zevotek's CEO, Rob Babkie, said, "The press coverage shows that Zevotek's Ionic Bulb has drawn the attention of influential journalists and major media outlets. The appearances in The Huffington Post and Marie Claire clearly demonstrate the Ionic Bulb is a serious product that is naturally positioned as being green and a money saver, two of the hottest consumer trends in the world. I am excited by Danny Seo's positive sentiments about Zevotek's Ionic Bulb and the potential for more exposure he may bring through his efforts to encourage Americans to live a greener lifestyle."
About the Company:
Zevotek, Inc. plans to market and sell a range of innovative personal and home care items. Zevotek has a license to sell an energy saving compact fluorescent light bulb (CFL) named the Ionic Bulb, a light bulb designed for consumer use by combining the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL).The Company sells the Ionic Bulb through TV infomercials and the Internet and plans to market Ionic Bulbs through catalogs, magazines and major U.S. retail and specialty stores. The Company's 1 minute and 2 minute Ionic Bulb TV ads are designed to air on national cable channels, local broadcast channels and TV superstations. Zevotek directly sells the Ionic Bulb to consumers through http://www.newionicbulb.com and www.amazon.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Forward-looking statements in this release with respect to the Zevotek, Inc.'s business, financial condition and results of operations, as well as matters of timing and effectiveness of marketing the Ionic Bulb are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond Zevotek, Inc.'s control with respect to market acceptance of their products, whether financing will be available, the plans for Zevotek, Inc. to market and sell products as well as certain other risk factors which are and may be detailed from time to time in Zevotek, Inc.'s filings with the Securities and Exchange Commission.
This press release contains forward-looking statements. The words or phrases 'may,' 'intends,' 'expects,' 'estimate,' 'indicate,' 'plans,' 'anticipates,' 'could,' 'if,' 'will,' 'should' or similar expressions are intended to identify 'forward-looking statements.' Actual results could differ materially from those projected in forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Zevotek, Inc. cautions readers not to place undue reliance on such statements. Unless otherwise required by applicable law, Zevotek, Inc. does not undertake, and Zevotek, Inc. specifically disclaims any obligation to update any forward- looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Zevotek, Inc.
CONTACT: Zevotek, Inc.
Jeff Carlson
949.375.3208
MTCH gapping up nicely
Morning all